Amyris Investors Reach $13.5M Deal In Inflated Royalties Suit

A California federal judge granted final approval to a $13.5 million settlement between chemical products manufacturer Amyris Inc. and investors who claimed the company overstated its royalty revenue, while awarding class...

Already a subscriber? Click here to view full article